PFE (Pfizer) How high will it go? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go?

PFE 26.33

+1.7%

10:01 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mkilloran who wrote (7631)	5/8/1999 1:17:00 AM
From: BigKNY3	Read Replies (1) of 9523

MK <<tell Smith Barney to look at the UK Sweden and Canada where a marketing program and a sales force are in place to sell MUSE.>> Do you have any numbers to support your statement? Total international MUSE sales in the the first quarter of 1999 were only $1.6 million down from $6.3 million in the 4th Qt 1998. MK <<Also Smith Barney neglected to include Alibra the next generation product from Vivus which will be marketed to a larger portion of the ED population with less side effects than MUSE..>> The primary product problem with MUSE is neither side effects or efficacy, it is the delivery system...the same delivery system that will be used by Alibra. Sorry, MK, I am still not optimistic about the future prospects of transurethral products. Difficult products to market in the age or managed care, busy waiting rooms and oral ED products .....compounded by the abilities of the management team for the only company in the world that is developing them. BigKNY3

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next